Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Non-Current Assets (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Non-Current Assets for 9 consecutive years, with $510525.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 34.77% year-over-year to $510525.0, compared with a TTM value of $2.4 million through Dec 2025, down 20.2%, and an annual FY2025 reading of $559363.0, down 24.31% over the prior year.
  • Non-Current Assets was $510525.0 for Q4 2025 at Neuroone Medical Technologies, down from $559363.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $879353.0 in Q2 2023 and bottomed at $510525.0 in Q4 2025.
  • Average Non-Current Assets over 5 years is $683912.2, with a median of $666946.0 recorded in 2024.
  • The sharpest move saw Non-Current Assets soared 37.04% in 2023, then crashed 34.77% in 2025.
  • Year by year, Non-Current Assets stood at $607928.0 in 2021, then rose by 14.03% to $693233.0 in 2022, then increased by 5.21% to $729371.0 in 2023, then increased by 7.31% to $782665.0 in 2024, then plummeted by 34.77% to $510525.0 in 2025.
  • Business Quant data shows Non-Current Assets for NMTC at $510525.0 in Q4 2025, $559363.0 in Q3 2025, and $648734.0 in Q2 2025.